Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer
2024 · Diagnostic Pathology · 17 citations
https://doi.org/10.1186/s13000-024-01557-3
Wuhan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
22
Citations
2
h-index
1
i10-index
Aoling Huang is an academic researcher from Wuhan University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Cells and Metastasis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 2, co-authored 4 publications.
https://doi.org/10.1186/s13000-024-01557-3
https://doi.org/10.1016/j.csbj.2024.10.007
Click to start Chat